Jiangsu Hengrui Pharmaceuticals Co Ltd. JIANGSU HENGRUI MEDICINE is a security (CUSIP Y4446S105) tracked across SEC portfolio filings. 1 registered fund positions totaling $274K via N-PORT as of 2026-03-31.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Rayliant-ChinaAMC Transformative China Tech ETF | Rayliant Funds Trust | $274K | 165.84% |